The Role of Integrated Computed Tomography Positron-Emission Tomography in Esophageal Cancer: Staging and Assessment of Therapeutic Response

Seminars in Radiation Oncology

Volumn 17, Issue 1, 2007, Pages 29-37

  Erasmus, Jeremy J ^a   Munden, Reginald F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

computer tomography; esophageal cancer; induction therapy; positron emission tomography; response assessment; staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE INTERVAL; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; HUMAN; LYMPH NODE METASTASIS; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL;

CONTRAST MEDIA; ESOPHAGEAL NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33845481369     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2006.09.005     Document Type: Article

References (68)

1. Liberale G., Van Laethem J.L., Gay F., et al. The role of PET scan in the preoperative management of oesophageal cancer. Eur J Surg Oncol 9 (2004) 942-947
2. Rasanen J.V., Sihvo E.I., Knuuti M.J., et al. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol 8 (2003) 954-960
3. Lerut T., Flamen P., Ectors N., et al. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 6 (2000) 743-752
4. van Westreenen H.L., Westerterp M., Bossuyt P.M., et al. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 18 (2004) 3805-3812
5. Flamen P., Lerut A., Van Cutsem E., et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 18 (2000) 3202-3210
6. van Westreenen H.L., Heeren P.A., van Dullemen H.M., et al. Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations. J Gastrointest Surg 1 (2005) 54-61
7. Beseth B.D., Bedford R., Isacoff W.H., et al. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy. Am Surg 9 (2000) 827-831
8. Jones D.R., Parker Jr. L.A., Detterbeck F.C., et al. Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy. Cancer 5 (1999) 1026-1032
9. Cerfolio R.J., Bryant A.S., Ohja B., et al. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg 6 (2005) 1232-1241
10. Westerterp M., van Westreenen H.L., Reitsma J.B., et al. Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy-systematic review. Radiology 3 (2005) 841-851
11. Wieder H.A., Brucher B.L., Zimmermann F., et al. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 5 (2004) 900-908
12. Yang Q., Cleary K.R., Yao J.C., et al. Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen. Dis Esophagus 1 (2004) 38-43
13. Kroep J.R., Van Groeningen C.J., Cuesta M.A., et al. Positron emission tomography using 2-deoxy-2-[18F]-fluoro-D-glucose for response monitoring in locally advanced gastroesophageal cancer: A comparison of different analytical methods. Mol Imaging Biol 5 (2003) 337-346
14. Swisher S.G., Ajani J.A., Komaki R., et al. Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 1 (2003) 120-127
15. Flamen P., Van Cutsem E., Lerut A., et al. Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol 3 (2002) 361-368
16. Kato H., Kuwano H., Nakajima M., et al. Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer. Am J Surg 3 (2002) 279-283
17. Downey R.J., Akhurst T., Ilson D., et al. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: Results of a prospective trial. J Clin Oncol 3 (2003) 428-432
18. Weber W.A., Ott K., Becker K., et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 12 (2001) 3058-3065
19. Brucher B.L., Weber W., Bauer M., et al. Neoadjuvant therapy of esophageal squamous cell carcinoma: Response evaluation by positron emission tomography. Ann Surg 3 (2001) 300-309
20. Song S.Y., Kim J.H., Ryu J.S., et al. FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer. Int J Radiat Oncol Biol Phys 4 (2005) 1053-1059
21. Meltzer C.C., Luketich J.D., Friedman D., et al. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography. Clin Nucl Med 11 (2000) 882-887
22. Block M.I., Patterson G.A., Sundaresan R.S., et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 3 (1997) 770-776 discussion 76-77
23. Wren S.M., Stijns P., and Srinivas S. Positron emission tomography in the initial staging of esophageal cancer. Arch Surg 9 (2002) 1001-1006 discussion 6-7
24. Kole A.C., Plukker J.T., Nieweg O.E., et al. Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer 4 (1998) 521-527
25. Bar-Shalom R., Guralnik L., Tsalic M., et al. The additional value of PET/CT over PET in FDG imaging of oesophageal cancer. Eur J Nucl Med Mol Imaging 8 (2005) 918-924
26. Cerfolio R.J., Ojha B., Mukherjee S., et al. Positron emission tomography scanning with 2-fluoro-2-deoxy-d-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma. J Thorac Cardiovasc Surg 4 (2003) 938-944
27. American Joint Commission on Cancer. Esophagus. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). American Joint Committee on Cancer cancer staging manual. (ed 6). (2002), Springer-Verlag, New York 301-346
28. Wallace M.B., Nietert P.J., Earle C., et al. An analysis of multiple staging management strategies for carcinoma of the esophagus: Computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy. Ann Thorac Surg 4 (2002) 1026-1032
29. Harewood G.C., and Wiersema M.J. A cost analysis of endoscopic ultrasound in the evaluation of pancreatic head adenocarcinoma. Am J Gastroenterol 9 (2001) 2651-2656
30. Rosch T. Endosonographic staging of esophageal cancer: A review of literature results. Gastrointest Endosc Clin N Am 3 (1995) 537-547
31. Hunerbein M., Ulmer C., Handke T., et al. Endosonography of upper gastrointestinal tract cancer on demand using miniprobes or endoscopic ultrasound. Surg Endosc 4 (2003) 615-619
32. Heeren P.A., van Westreenen H.L., Geersing G.J., et al. Influence of tumor characteristics on the accuracy of endoscopic ultrasonography in staging cancer of the esophagus and esophagogastric junction. Endoscopy 11 (2004) 966-971
33. Berger A.C., and Scott W.J. Noninvasive staging of esophageal carcinoma. J Surg Res 1 (2004) 127-133
34. Rice T.W., Blackstone E.H., Adelstein D.J., et al. Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma. J Thorac Cardiovasc Surg 5 (2003) 1091-1102
35. Lowe V.J., Booya F., Fletcher J.G., et al. Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer. Mol Imaging Biol 7 (2005) 422-430
36. Rice T.W. Clinical staging of esophageal carcinoma. CT, EUS, and PET. Chest Surg Clin N Am 3 (2000) 471-485
37. Kneist W., Schreckenberger M., Bartenstein P., et al. Positron emission tomography for staging esophageal cancer: Does it lead to a different therapeutic approach?. World J Surg 10 (2003) 1105-1112
38. Heeren P.A., Jager P.L., Bongaerts F., et al. Detection of distant metastases in esophageal cancer with (18)F-FDG PET. J Nucl Med 6 (2004) 980-987
39. Flanagan F.L., Dehdashti F., Siegel B.A., et al. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 2 (1997) 417-424
40. Quint L.E., Hepburn L.M., Francis I.R., et al. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer 7 (1995) 1120-1125
41. Romagnuolo J., Scott J., Hawes R.H., et al. Helical CT versus EUS with fine needle aspiration for celiac nodal assessment in patients with esophageal cancer. Gastrointest Endosc 6 (2002) 648-654
42. Parmar K.S., Zwischenberger J.B., Reeves A.L., et al. Clinical impact of endoscopic ultrasound-guided fine needle aspiration of celiac axis lymph nodes (M1a disease) in esophageal cancer. Ann Thorac Surg 3 (2002) 916-920 discussion 20-21
43. Eloubeidi M.A., Wallace M.B., Reed C.E., et al. The utility of EUS and EUS-guided fine needle aspiration in detecting celiac lymph node metastasis in patients with esophageal cancer: A single-center experience. Gastrointest Endosc 6 (2001) 714-719
44. Luketich J.D., Friedman D.M., Weigel T.L., et al. Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg 4 (1999) 1133-1136 discussion 36-37
45. Weber W.A., and Ott K. Imaging of esophageal and gastric cancer. Semin Oncol 4 (2004) 530-541
46. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomised controlled trial. Lancet 9319 (2002) 1727-1733
47. Kelsen D.P., Ginsberg R., Pajak T.F., et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 27 (1998) 1979-1984
48. Eloubeidi MA, Wallace MB, Hoffman BJ, et al: Predictors of survival for esophageal cancer patients with and without celiac axis lymphadenopathy: impact of staging endosonography. Ann Thorac Surg 2001; 1:212-9; discussion 19-20.
49. Swisher S.G., Hunt K.K., Holmes E.C., et al. Changes in the surgical management of esophageal cancer from 1970 to 1993. Am J Surg 6 (1995) 609-614
50. Berger A.C., Farma J., Scott W.J., et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 19 (2005) 4330-4337
51. Roth J.A., Pass H.I., Flanagan M.M., et al. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 2 (1988) 242-248
52. Walsh T.N., Noonan N., Hollywood D., et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 7 (1996) 462-467
53. Urba S.G., Orringer M.B., Turrisi A., et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2 (2001) 305-313
54. Swisher S.G., Hofstetter W., Wu T.T., et al. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg 5 (2005) 810-817 discussion 17-20
55. Blackstock A.W., Farmer M.R., Lovato J., et al. A prospective evaluation of the impact of 18-F-fluoro-deoxy-D-glucose positron emission tomography staging on survival for patients with locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 2 (2006) 455-460
56. Brink I., Hentschel M., Bley T.A., et al. Effects of neoadjuvant radio-chemotherapy on 18F-FDG-PET in esophageal carcinoma. Eur J Surg Oncol 5 (2004) 544-550
57. Rizk N., Downey R.J., Akhurst T., et al. Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection. Ann Thorac Surg 3 (2006) 1076-1081
58. Swisher S.G., Erasmus J., Maish M., et al. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 8 (2004) 1776-1785
59. Swisher S.G., Maish M., Erasmus J.J., et al. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 4 (2004) 1152-1160 discussion 52-60
60. Arslan N., Miller T.R., Dehdashti F., et al. Evaluation of response to neoadjuvant therapy by quantitative 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography in patients with esophageal cancer. Mol Imaging Biol 4 (2002) 301-310
61. Nakamura R., Obara T., Katsuragawa S., et al. Failure in presumption of residual disease by quantification of FDG uptake in esophageal squamous cell carcinoma immediately after radiotherapy. Radiat Med 4 (2002) 181-186
62. Bhargava P., Reich P., Alavi A., et al. Radiation-induced esophagitis on FDG PET imaging. Clin Nucl Med 10 (2003) 849-850
63. Hautzel H., Muller-Gartner H., et al. Early changes in fluorine-18-FDG uptake during radiotherapy. J Nucl Med 38 (1997) 1384-1386
64. Pan T., Mawlawi O., Nehmeh S.A., et al. Attenuation correction of PET images with respiration-averaged CT images in PET/CT. J Nucl Med 9 (2005) 1481-1487
65. Beyer T., Antoch G., Blodgett T., et al. Dual-modality PET/CT imaging: The effect of respiratory motion on combined image quality in clinical oncology. Eur J Nucl Med Mol Imaging 4 (2003) 588-596
66. Goerres G.W., Kamel E., Heidelberg T.N., et al. PET-CT image co-registration in the thorax: Influence of respiration. Eur J Nucl Med Mol Imaging 3 (2002) 351-360
67. Goerres G.W., Burger C., Kamel E., et al. Respiration-induced attenuation artifact at PET/CT: Technical considerations. Radiology 3 (2003) 906-910
68. de Juan R., Seifert B., Berthold T., et al. Clinical evaluation of a breathing protocol for PET/CT. Eur Radiol 6 (2004) 1118-1123